Live feed07:00:00·30dPRReleasevia QuantisnowBruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease BiologyByQuantisnow·Wall Street's wire, on your screen.BRKR· Bruker CorporationIndustrials